GlassScriptPhysician profile
Tara S Abraham
NPI 1396035580
$1,247.66
in general payments reported to CMS, 2019-2025
23 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $109 · 2021: $99.93 · 2022: $198 · 2023: $310 · 2024: $139 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.88 | 2019-2023 | Liletta |
| Pfizer INC. | $187.19 | 2019-2024 | |
| Astellas Pharma Global Development | $118.44 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $114.14 | 2023-2024 | Acessa Provu System, Coolseal Generator, Aptima |
| Astellas Pharma US INC | $96.00 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $92.51 | 2023-2025 | Myfembree |
| Ethicon US, LLC | $78.82 | 2025 | Enseal |
| Bayer Healthcare Pharmaceuticals INC. | $42.45 | 2022-2023 | |
| Aesculap, INC. | $35.47 | 2019 | |
| Becton, Dickinson and Company | $32.67 | 2024-2025 | Bd Max System, Bd Max Instrument, Bd Onclarity |
| Myovant Sciences INC. | $24.69 | 2022 | |
| Sage Therapeutics, LLC | $23.74 | 2024 | |
| Therapeuticsmd, INC. | $23.53 | 2020 | |
| Biogen, INC. | $19.48 | 2023 | |
| Millicent US INC | $18.90 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.89 | 2019 | |
| Aspira Women'S Health INC | $16.46 | 2023 | Ova1 |
| Amag Pharmaceuticals, INC. | $16.44 | 2019 | |
| Allergan, INC. | $16.00 | 2020 | |
| Coopersurgical, INC. | $15.68 | 2022 | |
| Minerva Surgical, INC | $13.44 | 2022 | |
| Daiichi Sankyo INC. | $12.42 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.